ERK1/2 activation in quercetin-treated BEAS-2B cell plays a role in Nrf2-driven HO-1 expression

Molecular and Cellular Toxicology

Volumn 7, Issue 4, 2011, Pages 347-355

  Lee, Yoon Jin ^a   Song, Jun Hwan ^a   Oh, Myung Ho ^a   Lee, Yong Jin ^a   Kim, Yong Bae ^a   Im, Jae Hyuk ^a   Lee, Sang Han ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

BEAS 2B cells; ERK1 2; Gene silencing; Heme oxygenase 1; Nrf2; Quercetin

Indexed keywords

EID: 84863049405     PISSN: 1738642X     EISSN: 20928467     Source Type: Journal    
DOI: 10.1007/s13273-011-0044-7     Document Type: Article

References (23)

1. A. Murakami H. Ashida J. Terao 2008 Multitargeted cancer prevention by quercetin Cancer Lett 269 315 325 18467024 10.1016/j.canlet.2008.03.046 1:CAS:528:DC%2BD1cXhtFWlsrjE
2. Z. J. Sun, et al. 2010 Activation of PI3K/Akt/IKK-alpha/ NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin Apoptosis 15 850 863 20386985 10.1007/s10495-010-0497-5 1:CAS:528:DC%2BC3cXotVOltbw%3D
3. T. W. Nam, et al. 2008 The flavonoid quercetin induces apoptosis and inhibits migration through a MAPKdependent mechanism in osteoblasts J Bone Miner Metab 26 551 560 18979154 10.1007/s00774-008-0864-2 1:CAS:528: DC%2BD1cXhtlWhtb%2FO
4. W. Watjen, et al. 2005 Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis J Nutr 135 525 531 15735088 (Pubitemid 40365213)
5. R. Ferraresi, et al. 2005 Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin Free Radic Res 39 1249 1258 16298752 10.1080/10715760500306935 1:CAS:528:DC%2BD2MXht1agtrnN (Pubitemid 41601428)
6. M. C. Myhrstad, et al. 2002 Flavonoids increase the intracellular glutathione level by transactivation of the γ-glutamylcysteine synthetase catalytical subunit promoter Free Radic Biol Med 32 386 393 11864778 10.1016/S0891-5849(01)00812-7 1:CAS:528:DC%2BD38XhsFWns74%3D (Pubitemid 34178348)
7. T. W. Kensler N. Wakabayashi S. Biswal 2007 Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway Annu Rev Pharmacol Toxicol 47 89 116 16968214 10.1146/annurev.pharmtox.46.120604.141046 1:CAS:528:DC%2BD2sXit1altrg%3D
8. J. S. Kim, et al. 2010 Quercetin-3-O-beta-d-glucuronopyranoside (QGC)-induced HO-1 expression through ERK and PI3K activation in cultured feline esophageal epithelial cells Fitoterapia 81 85 92 19686811 10.1016/j.fitote. 2009.08.008 1:CAS:528:DC%2BD1MXhs1WnsLfF
9. T. T. Nguyen, et al. 2004 The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells Carcinogenesis 25 647 659 14688022 10.1093/carcin/bgh052 1:CAS:528: DC%2BD2cXjsVektbc%3D (Pubitemid 38618516)
10. C. T. Yeh G. C. Yen 2005 Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells Carcinogenesis 26 2138 2148 16033772 10.1093/carcin/bgi185 1:CAS:528: DC%2BD2MXht1entL7J (Pubitemid 41672202)
11. L. E. Fredenburgh M. A. Perrella S. A. Mitsialis 2007 The role of heme oxygenase-1 in pulmonary disease Am J Respir Cell Mol Biol 36 158 165 16980551 10.1165/rcmb.2006-0331TR 1:CAS:528:DC%2BD2sXhvFWjurw%3D (Pubitemid 46233468)
12. R. Vidya Priyadarsini, et al. 2010 The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition Eur J Pharmacol 649 84 91 20858478 10.1016/j.ejphar.2010.09.020 1:CAS:528:DC%2BC3cXhtlKktbjI
13. E. J. Choi S. M. Bae W. S. Ahn 2008 Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells Arch Pharm Res 31 1281 1285 18958418 10.1007/s12272-001-2107-0 1:CAS:528:DC%2BD1cXht12lsL3L
14. N. Gulati, et al. 2006 The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway Anticancer Res 26 1177 1181 16619521 1:CAS:528:DC%2BD28XktFWmsb4%3D
15. J. S. Clerkin R. Naughton C. Quiney T. G. Cotter 2008 Mechanisms of ROS modulated cell survival during carcinogenesis Cancer Lett 266 30 36 18372105 10.1016/j.canlet.2008.02.029 1:CAS:528:DC%2BD1cXmsFKlu7c%3D
16. C. P. Xavier, et al. 2009 Luteolin quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells Cancer Lett 281 162 170 19344998 10.1016/j.canlet.2009.02.041 1:CAS:528:DC%2BD1MXnsFajs7s%3D
17. K. W. Lee, et al. 2008 Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine Cancer Res 68 946 955 18245498 10.1158/0008-5472.CAN-07-3140 1:CAS:528:DC%2BD1cXhtlygur0%3D (Pubitemid 351206774)
18. Y. J. Lee, et al. 2011 Cadmium-induced up-regulation of aldo-keto reductase 1C3 expression in human nasal septum carcinoma RPMI-2650 cells: Involvement of reactive oxygen species and phosphatidylinositol 3-kinase/Akt Environ Toxicol Pharmacol 31 469 478 21787718 10.1016/j.etap.2011.03.006 1:CAS:528:DC%2BC3MXkvFejsrk%3D
19. T. Yamamoto, et al. 2008 Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity Mol Cell Biol 28 2758 2770 18268004 10.1128/MCB.01704-07 1:CAS:528:DC%2BD1cXksFWqt7w%3D (Pubitemid 351542373)
20. Y. S. Keum, et al. 2008 3-Morpholinopropyl isothiocyanate is a novel synthetic isothiocyanate that strongly induces the antioxidant response element-dependent Nrf2-mediated detoxifying/antioxidant enzymes in vitro and in vivo Carcinogenesis 29 594 599 17916901 10.1093/carcin/bgm208 1:CAS:528:DC%2BD1cXjsVams7o%3D (Pubitemid 351404877)
21. S. Homma, et al. 2009 Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer Clin Cancer Res 15 3423 3432 19417020 10.1158/1078-0432.CCR-08-2822 1:CAS:528:DC%2BD1MXmtVKmu7k%3D
22. V. Rubio, et al. 2011 Essential role of Nrf2 in protection against hydroquinone- and benzoquinone-induced cytotoxicity Toxicol in Vitro 25 521 529 21059386 10.1016/j.tiv.2010.10.021 1:CAS:528:DC%2BC3MXhtlegtb4%3D
23. X. J. Wang, et al. 2008 Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 Carcinogenesis 29 1235 1243 18413364 10.1093/carcin/bgn095 1:CAS:528:DC%2BD1cXot1Wjsbg%3D (Pubitemid 351958704)